Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for Six Months Ending September 30, 2022 and Year Ending March 31, 2023
July 29, 2022 at 02:10 am EDT
Share
Japan Lifeline Co., Ltd. provided consolidated earnings guidance for Six months ending September 30, 2022 and Year ending March 31, 2023. For Six months ending September 30, 2022 the company expected net sales of JPY 24,861 million, operating profit of JPY 4,403 million, profit attributable to owners of parent of JPY 3,193 million, Basic earnings per share of JPY 40.74 per basic share.
For Year ending March 31, 2023 the company expected net sales of JPY 51,527 million, operating profit of JPY 10,011 million, profit attributable to owners of parent of JPY 7,274 million, Basic earnings per share of JPY 93.06 per basic share.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
